US Patent Issued to HANMI PHARM. on May 17 for "Triple glucagon/GLP-1/GIP receptor agonist" (South Korean Inventors)

Press/Media: Press / Media

Period2022 May 17

Media coverage

1

Media coverage

  • TitleUS Patent Issued to HANMI PHARM. on May 17 for "Triple glucagon/GLP-1/GIP receptor agonist" (South Korean Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date22/5/17
    Personsjin woo Park